These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7471063)

  • 1. Sedimentation of DNA from L1210 cells after treatment with 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) or 1-beta-D-arabinofuranosylcytosine or both drugs.
    Roberts D; Hilliard S; Peck C
    Cancer Res; 1980 Nov; 40(11):4225-31. PubMed ID: 7471063
    [No Abstract]   [Full Text] [Related]  

  • 2. Response of L1210 leukemia to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea plus 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside).
    Roberts D; Peck C; Hilliard S; Karas JG
    Cancer Res; 1981 Oct; 41(10):3891-5. PubMed ID: 7284998
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative cytotoxic and cytokinetic effects of the epipodophyllotoxins 4'-demethylepipodophyllotoxin-9-(4,6-O-2-ethylidene-beta-D-glucopyranoside) and 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) and their metabolites on human leukemic lymphoblasts.
    Dow LW; Sinkule JA; Look AT; Horvath A; Evans WE
    Cancer Res; 1983 Dec; 43(12 Pt 1):5699-706. PubMed ID: 6580063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity.
    Wozniak AJ; Ross WE
    Cancer Res; 1983 Jan; 43(1):120-4. PubMed ID: 6847761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates.
    Schott H; Schwendener RA
    Anticancer Drug Des; 1996 Sep; 11(6):451-62. PubMed ID: 8836110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells.
    Vietti TJ; Valeriote FA; Kalish R; Coulter D
    Cancer Treat Rep; 1978 Sep; 62(9):1313-20. PubMed ID: 688275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed toxicity of 4'-demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) in mice.
    Avery TL; Roberts D; Price RA
    Cancer Chemother Rep; 1973 Apr; 57(2):165-73. PubMed ID: 4742496
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of uptake and binding of two epipodophyllotoxin glucopyranosides, 4'-demethyl epipodophyllotoxin thenylidene-beta-D-glucoside and 4'-demethyl epipodophyllotoxin ethylidene-beta-D-glucoside, in the L1210 leukemia cell.
    Allen LM
    Cancer Res; 1978 Aug; 38(8):2549-54. PubMed ID: 667850
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycosylated podophyllotoxin congeners: loss of microtubule inhibition and permission of invasion in vitro.
    Mareel MM; Dragonetti CH; De Bruyne GK; Van Cauwenberge RM
    J Natl Cancer Inst; 1982 Dec; 69(6):1367-74. PubMed ID: 6958912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitro.
    Yalowich JC; Ross WE
    Cancer Res; 1984 Aug; 44(8):3360-5. PubMed ID: 6744270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213.
    Rivera G; Avery T; Roberts DW
    Eur J Cancer (1965); 1975 Sep; 11(9):639-47. PubMed ID: 1220978
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antitumor effect of etoposide and its analogs].
    Kuramochi H; Okamoto K; Nishikawa K; Nagamine S; Takahashi K
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2196-201. PubMed ID: 4062319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4'-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) and 4'-demethylepipodophyllotoxin 9-(4.6-0-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213) in childhood cancer: preliminary observations.
    Rivera G; Avery T; Pratt C
    Cancer Chemother Rep; 1975; 59(4):743-9. PubMed ID: 1100225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 4,6-
    Cheng J; Zhao W; Yao H; Shen Y; Zhang Y; Li YZ; Qi Q; Wongprasert K; Tang YJ
    J Med Chem; 2020 Mar; 63(6):2877-2893. PubMed ID: 32084316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of leukemia L1210 in mice with 1-beta-D-arabinofuranosylcytosine hydrochloride. II. Effectiveness against intracerebrally and subcutaneously inoculated leukemic cells.
    Kline I; Venditti JM; Tyrer DD; Mantel N; Goldin A
    Cancer Res; 1966 Sep; 26(9):1930-7. PubMed ID: 5924958
    [No Abstract]   [Full Text] [Related]  

  • 17. Antitumor activities of newly synthesized N4-acyl-1-beta-D-arabinofuranosylcytosine.
    Aoshima M; Tsukagoshi S; Sakurai Y; Oh-ishi J; Ishida T
    Cancer Res; 1976 Aug; 36(8):2726-32. PubMed ID: 1277182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners.
    Loike JD; Brewer CF; Sternlicht H; Gensler WJ; Horwitz SB
    Cancer Res; 1978 Sep; 38(9):2688-93. PubMed ID: 679171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice.
    Neil GL; Moxley TE; Manak RC
    Cancer Res; 1970 Aug; 30(8):2166-72. PubMed ID: 4990003
    [No Abstract]   [Full Text] [Related]  

  • 20. Antitumor effect and mode of action of 1-beta-D-arabinofuranosylcytosine 5'-phosphate in leukemia L1210.
    Schrecker AW; Goldin A
    Cancer Res; 1968 Apr; 28(4):802-3. PubMed ID: 5649067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.